I like to think about technology and how it can improve our health and our sustainable future.

 

 

I am a Visiting Expert at the European Medicines Agency and an advisor to the Pediatric Therapeutics Initiative at Boston Children's Hospital. Previously, I worked in London, Boston, and New York as an investor and investment banker at Blackstone, Bain Capital, and Goldman Sachs. My work has been published in Science, JAMA, and the New England Journal of Medicine; cited by policymakers in the US and Europe; and covered by the Wall Street Journal and Le Figaro. I studied Biomedicine at Harvard, where I am also completing my medical and business training at Harvard Medical School and Harvard Business School.


The empirical findings of this study raise interesting issues about the future of drug development . . .
— Dr. Robert Califf, Commissioner of the FDA, et al.

Posts